A new federal rule aims to overhaul the No Surprises Act protocols, particularly as large volumes of disputes are pushed to ...
The industry has been waiting for regulators to finalize the rule amid snowballing concerns about how insurers and providers settle out-of-network claims. The regulation is aimed at making that ...
Healthcare providers, physician groups, hospitals, health plans, insurers, staffing companies, investors, and private equity-backed healthcare platforms should prepare for operational, reimbursement, ...
The US Departments of Treasury, Labor, and Health and Human Services have issued a sweeping final rule (CMS-9897-F) implementing significant ...
Optional mediation language preserves flexibility by allowing parties to decide, once a dispute arises, whether mediation makes sense under the circumstances. At the same time, pa ...
Alternative dispute resolution, a process by which a neutral third party helps parties reach an agreement without litigation, is more successful during the pre-complaint stage compared with the formal ...
The departments of Health and Human Services, Labor and the Treasury issued a final rule May 28 intended to improve the functioning of the No Surprises Act independent dispute resolution process.
A proposed rule pertaining to the controversial No Surprises Act Dispute Resolution process, would, if finalized, require payers to provide additional information at the time of initial payment or ...
The Trump administration has finalized a long-awaited overhaul of the system used to settle out-of-network billing disputes between insurers and providers, amid growing criticism that the process is ...
4 天on MSN
South African banks urged to overhaul fraud dispute processes as digital banking scams surge
South Africa's digital fraud crisis is exposing weaknesses in bank dispute processes, with industry experts calling for ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg, bevacizumab gamma) for the treatment of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果